LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
LABCORP HOLDINGS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$318.83+0.88 (+0.28%)
Close on Oct 19, 2026
- Market cap
- $26.14B
- P/E (TTM)
- 26.4
- Dividend yield
- 0.90%
Labcorp statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Labcorp | Industry median |
|---|---|---|
| Market Cap | $25.86B | $1.11B |
| Enterprise Value | $31.57B | $1.41B |
| PE Ratio | 26.37 | 22.72 |
| PS Ratio | 1.80 | 1.60 |
| PB Ratio | 3.00 | 3.03 |
| P/FCF Ratio | 22.38 | 20.54 |
| P/OCF Ratio | 15.78 | 15.44 |
Enterprise value
| Measure | Labcorp | Industry median |
|---|---|---|
| EV / Sales | 2.20 | 1.69 |
| EV / EBITDA | 14.40 | 14.40 |
| EV / EBIT | 21.10 | 19.04 |
| EV / FCF | 27.33 | 23.16 |
Income (trailing twelve months)
| Measure | Labcorp | Industry median |
|---|---|---|
| Revenue | $14.35B | $561.90M |
| Gross Profit | $4.14B | $173.32M |
| Operating Income | $1.50B | -$1.81M |
| Net Income | $1.00B | -$1.16M |
| EBITDA | $2.19B | -$20.72K |
| EPS (Diluted) | $12.09 | -$0.02 |
Margins
| Measure | Labcorp | Industry median |
|---|---|---|
| Gross Margin | 28.9% | 33.1% |
| Operating Margin | 10.4% | -4.45% |
| Profit Margin | 6.99% | -2.91% |
| EBITDA Margin | 15.3% | 2.41% |
| FCF Margin | 8.05% | 3.13% |
Returns
| Measure | Labcorp | Industry median |
|---|---|---|
| Return on Equity (ROE) | 11.7% | 1.84% |
| Return on Assets (ROA) | 5.48% | -3.06% |
| Return on Invested Capital (ROIC) | 8.69% | 2.11% |
| Return on Capital Employed (ROCE) | 9.12% | -0.57% |
Growth
| Measure | Labcorp | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.41% | 6.92% |
| Net Income Growth (YoY) | 31.3% | 19.6% |
| EPS Growth (YoY) | 33.3% | 25.8% |
| FCF Growth (YoY) | -8.45% | -6.04% |
| Revenue Growth (3Y CAGR) | 5.55% | 10.9% |
| Revenue Growth (5Y CAGR) | -0.04% | 13.2% |
| EPS Growth (3Y CAGR) | -9.19% | 19.8% |
| EPS Growth (5Y CAGR) | -8.01% | 9.29% |
Balance sheet
| Measure | Labcorp | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $141.80M | $48.71M |
| Total Debt | $5.86B | $140.00M |
| Net Cash (Debt) | -$5.72B | $205.49K |
| Net Cash Per Share | -$70.49 | $0.01 |
| Equity (Book Value) | $8.61B | $235.16M |
| Book Value Per Share | $106.13 | $3.48 |
| Tangible Book Value | -$2.10B | $703.69K |
| Working Capital | $1.69B | $30.48M |
Financial position
| Measure | Labcorp | Industry median |
|---|---|---|
| Current Ratio | 1.80 | 1.40 |
| Quick Ratio | 1.17 | 1.02 |
| Debt / Equity | 0.68 | 0.66 |
| Debt / EBITDA | 2.67 | 2.61 |
| Debt / FCF | 5.07 | 4.59 |
| Net Debt / EBITDA | 2.61 | 2.15 |
| Interest Coverage | 6.59 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Labcorp | Industry median |
|---|---|---|
| Operating Cash Flow | $1.64B | $3.10M |
| Capital Expenditures | -$483.20M | -$18.62M |
| Free Cash Flow | $1.16B | $23.73M |
| FCF Per Share | $14.24 | $0.37 |
Efficiency
| Measure | Labcorp | Industry median |
|---|---|---|
| Asset Turnover | 0.78 | 0.87 |
| Inventory Turnover | 19.07 | 11.67 |
| Revenue Per Employee | $202.09K | $228.48K |
| Profits Per Employee | $14.12K | -$5.75K |
| Employee Count | 71,000 | 910 |
Dividends and yields
| Measure | Labcorp | Industry median |
|---|---|---|
| Earnings Yield | 3.88% | -0.59% |
| FCF Yield | 4.47% | 1.74% |
| Dividend Yield | 0.90% | 0.61% |
| Buyback Yield | 2.71% | 0.32% |
| Shareholder Yield | 3.62% | 0.65% |
| Dividend Per Share | $2.88 | $1.30 |
| Dividend Growth (YoY) | 0.00% | 4.55% |
| Years of Dividend Growth | 0 | 4 |
| Payout Ratio | 23.9% | 14.1% |
| FCF Payout Ratio | 20.7% | 12.0% |
Shares
| Measure | Labcorp | Industry median |
|---|---|---|
| Shares Outstanding | 81,100,000 | 58,282,400 |
| Shares Change (YoY) | -1.46% | 2.68% |
| Shares Change (QoQ) | -1.70% | 0.32% |
| Float | 80,777,300 | 33,780,100 |
| Shares Held by Insiders | 0.40% | 16.4% |
| Shares Held by Institutions | 98.0% | 85.9% |
Taxes
| Measure | Labcorp | Industry median |
|---|---|---|
| Income Tax | $230.20M | $697.00K |
Scores
| Measure | Labcorp | Industry median |
|---|---|---|
| Graham Number | $169.91 | $19.59 |
| Graham Upside | -46.7% | -47.5% |
| Altman Z-Score | 3.37 | 2.05 |
| Piotroski F-Score | 7 | 5 |
| Beneish M-Score | -2.55 | -2.71 |
Calculated by StockData from Labcorp's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.